To submit a grant posting, please fill out our web form or download the form
so that you can email us at grants@alzforum.org.
List the sponsor name, amount, due date, and contact information. This is a free service.
Please Note: We remove grant postings after 6 months. If you would like your listing to be posted longer or taken down sooner,
please contact us at grants@alzforum.org.
Sponsor: National Institute on Aging
Award: Submit applications for this initiative using one of the following notices of funding opportunities (NOFOs) or any reissues of these announcements through the expiration date of this notice:
PAR-25-331 - Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional);
PAR-25-332 - Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional)
Due Date: This notice applies to due dates on or after March 11, 2025 and subsequent receipt dates through November 17, 2027.
Sponsor: National Institute on Aging
Award: Submit applications for this initiative using one of the following notice of funding opportunity (NOFO) or any reissues of these announcements through the expiration date of this notice:
PAR-25-331 - Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional); PAR-25-332 - Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional)
Due Date: This notice applies to due dates on or after March 11, 2025 and subsequent receipt dates through November 17, 2027.
Sponsor: National Institutes of Health
Award: Application budgets may not exceed $400,000 direct costs over a maximum three-year funding period. No more than $200,000 direct costs may be requested in any single year.
Due Date: Multiple due dates; see announcement.
Sponsor: National Institute on Aging
Award: Submit applications for this initiative using one of the following notices of funding opportunities (NOFOs) or any reissues of these announcements through the expiration date of this notice:
PAR-25-331 - Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional);
PAR-25-332 - Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional)
Due Date: This notice applies to due dates on or after March 11, 2025 and subsequent receipt dates through November 17, 2027 .
Sponsor: The Chan Zuckerberg Initiative (CZI)
Award: This grant is for an allocation of CZI’s GPU resource (minimum request of 96 GPU). This is an in-kind award; there are no cash funds, financial contributions, or fees of any kind associated with the award.
Due Date: Submitted applications will be downloaded for consideration at 1 p.m. Pacific Time on the third Wednesday of every month (through June 18, 2025) until cluster access is allocated. CZI reserves the right to stop accepting applications at any time.
Sponsor: National Institute on Aging
Award: Submit applications for this initiative using one of the following notice of funding opportunity (NOFO) or any reissues of these announcements through the expiration date of this notice: PAR-25-331 - Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional); PAR-25-332 - Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional).
Due Date: This notice applies to due dates on or after March 11, 2025 and subsequent receipt dates through November 17, 2027.
Sponsor: National Institutes of Health
Award: Application budgets may not exceed $400,000 total direct costs over a maximum three-year funding period. No more than $200,000 in direct costs may be requested in any single year.
Due Date: June 17, 2025 or June 15, 2026.
Sponsor: National Institute on Aging
Award: NIA intends to fund 1 award. The budget for direct costs may not exceed $3,750,000 per year. The maximum project period is 5 years.
Due Date: February 28, 2025.
Sponsor: The Michigan Center for Contextual Factors in Alzheimer’s Disease (MCCFAD)
Award: Funding for up to $30,000 in total costs (maximum of 8% allocated to indirect costs) for a relevant research proposal, pending NIA approval. Access to monthly mentoring with experts in the fields of epidemiology, culturally- sensitive care, health economics, and minority aging. Guidance in the development of independent NIH-funded projects. Advanced training in ADRD secondary data utilization through the Summer Data Immersion program.
Due Date: January 19, 2025
Sponsor: National Institute on Aging
Due Date: Estimated Publication Date of Notice of Funding Opportunity: December 31, 2024. First Estimated Application Due Date: March 07, 2025.
Sponsor: National Institute on Aging
Due Date: Estimated Publication Date of Notice of Funding Opportunity: December 31, 2024. First Estimated Application Due Date: March 07, 2025.
Sponsor: National Institute on Aging
Due Date: Estimated Publication Date of Notice of Funding Opportunity: December 15, 2024. First Estimated Application Due Date: February 15, 2025.
Sponsor: National Institute on Aging
Award: Award budgets are composed of salary and additional expenses. NIH will fund up to $42,500 per year in salary. NIH will fund up to $28,656 for additional expenses such as fringe benefits (e.g., health insurance for self and family members), travel to scientific meetings, and dissertation research costs in accordance with institutional policies. With the exception of costs associated with the dissertation (i.e., dissertation credits), no funds may be used to pay tuition or fees. Support is provided for up to two years.
Due Date: Multiple due dates; see announcement.
Sponsor: National Institute on Aging, National Institute of Allergy and Infectious Diseases
Award: This initiative relates to the following notices of funding opportunities (NOFOs): PAR-22-093 - Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional); PAR-22-094 - Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional).
Due Date: This notice applies to due dates on or after November 12, 2024 and subsequent receipt dates through December 31, 2027.
Sponsor: National Institutes of Health
Due Date: Multiple due dates; see announcement.
